We study the problem of learning personalized decision policies from observational data while accounting for possible unobserved confounding in the data-generating process. Previous approaches, which assume unconfoundedness, i.e., that no unobserved confounders affect both the treatment assignment as well as outcome, can lead to policies that actually introduce significant harm rather then benefit due to overeager intervention when some unobserved confounding is present, as is actually the case in most applications dealing with observational data. Instead, we calibrate policy learning for realistic violations of this unverifiable assumption with uncertainty sets motivated by sensitivity analysis in causal inference. Our framework for confounding-robust policy improvement optimizes the minimax regret of a candidate policy against a baseline standard-of-care policy over an uncertainty set for propensity weights. We prove that if the uncertainty set is well-specified, our robust policy, when applied in practice, will do no worse than the baseline and improve upon it if possible. We characterize the adversarial optimization subproblem and use efficient algorithmic solutions to optimize over parametrized spaces of decision policies such as logistic treatment assignment and decision trees. We assess our methods on synthetic data and on a large clinical trial of acute ischaemic stroke treatment, demonstrating that hidden confounding can hinder existing policy learning approaches and lead to unwarranted harm, while our robust approach guarantees safety and focuses on well-evidenced improvement, a necessity for making personalized treatment policies learned from observational data reliable in practice.
Introduction
The problem of learning personalized decision policies to study "what works and for whom" in areas such as medicine, e-commerce, and civics often endeavors to draw insights from increasingly rich and plentiful observational data, such as electronic medical records (EMRs), since data from randomized controlled experiments may be scarce, costly, or unethical to ⇤ kallus@cornell.edu acquire. A variety of methods have been proposed to address the corresponding problem of policy learning from observational data (Beygelzimer and Langford 2009 , Dudik et al. 2014 , Kallus 2017a ,b, Kallus and Zhou 2018 , Kitagawa and Tetenov 2018 , Wager and Athey 2017a . These methods, as well as approaches to predict individual-level causal effects from observational data (Künzel et al. 2017 , Nie and Wager 2017 , Shalit et al. 2017 , Wager and Athey 2017b , operate under the controversial assumption of unconfoundedness, which requires that the data are sufficiently informative such that no confounders that jointly affect treatment assignment and individual response are unobserved (Rubin 1974) , effectively requiring that assignment is as if at random once we control for observables. This key assumption may be always made to hold ex ante by directly controlling the treatment assignment policy as in a randomized controlled experiment, but in other domains of key interest such as personalized medicine where EMRs are increasingly being analyzed ex post, unconfoundedness is an assumption that may never truly fully hold in fact.
Assuming unconfoundedness, also called ignorability, conditional exogeneity, or selection on observables, is controversial because it is fundamentally unverifiable since the counterfactual distribution is never identified from the data (Imbens and Rubin 2015) . Thus, insights from observational studies, which passively study treatment-outcome data without intervening on treatment, are always vulnerable to this fundamental critique. For example, studying drug efficacy by assessing outcomes of those prescribed the drug during the course of normal clinical practice may make a drug look less clinically effective if those who were prescribed the drug were sicker to begin with and therefore would have had worse outcomes regardless. Conversely, if the drug was correctly prescribed only to the patients who would most benefit from it, it may make the drug appear to be falsely effective for all patients. These issues can potentially be alleviated by controlling for more baseline factors that may have affected treatment choices but they can never really be fully eliminated in practice.
Conclusions drawn from healthcare databases such as claims data are particularly vulnerable to unobserved confounding because although they record administrative interactions and diagnostic codes, they are uninformative about medical histories, notes on patient severity, observations, nor monitoring of clinical outcomes, i.e., the key clinical information which may drive a physician's treatment choices. EMRs provide great promise for enabling richer personalized medicine from observational data because they record the entire patient treatment and diagnostic history, past medical history and comorbidities, as well as fine-grained information regarding patient response such as vital signs (Hoffman and Williams 2011) . The growing adoption of richer EMRs can both provide higher precision for personalized treatment and render unconfoundedness more plausible, since the data includes more of the information regarding patient history and outcomes that informs physician decision-making, yet unconfoundedness, an ideal stylized assumption, still may never be fully satisfied in practice.
Because unconfoundedness may fail to hold, existing policy learning methods that operate under this assumption can lead to personalized decision policies that seek to exploit individuallevel effects that are not really there, may intervene where not necessary, and may in fact lead to net harm rather than net good. Such dangers constitute obvious impediments to the use of policy learning to enhance decision making in such sensitive applications as medicine, public policy, and civics, where reliable and safe algorithms are critical to implementation. Clearly, a policy that could potentially introduce additional harm, toxicity, or risk to patients compared to current standards of care is an unacceptable replacement, and an algorithm that could potentially give rise to such a policy is unusable in medical and other sensitive settings.
To address this deficiency, in this paper we develop a framework for confounding-robust policy learning and improvement that can ensure that the personalized decision policy derived from observational data, which inevitably will have some unobserved confounding, will do no worse than a current policy such as the current standard of care and, in fact, will do better if the data can indeed support it. We do so by recognizing and accounting for the potential confounding in the data and requiring that the learned policy improve upon the baseline no matter the direction of confounding. Thus, we calibrate personalized decision policies to address sensitivity to realistic violations of the unconfoundedness assumption. For the purposes of informing reliable and personalized decision-making that leverages modern machine learning, our work highlights that statistical point identification of individual-level causal effects, which previous approaches crucially rely on, may not at all be necessary for successfully learning effective policies that reliably improve on unpersonalized standards of care, but accounting for the lack of point identification is necessary.
Functionally, our approach is to optimize a policy to achieve the best worst-case improvement relative to a baseline treatment assignment policy (such as treat all or treat none), where the improvement is measured using a weighted average of outcomes and weights take values in an uncertainty set around the nominal inverse propensity weights (IPW). This generalizes the popular class of IPW-based approaches to policy learning, which optimize an unbiased estimator for policy value under unconfoundedness (Beygelzimer and Langford 2009 , Kitagawa and Tetenov 2018 , Li et al. 2011 , Swaminathan and Joachims 2015a . Unlike standard approaches, in our approach the choice of baseline is material and changes the resulting policy chosen by our method. This framing supports reliable decision-making in practice, as often a practitioner is seeking evidence of substantial improvement upon the standard of care or a default option, and/or the intervention under consideration introduces risk of toxicity or adverse effects and should not be applied without strong evidence.
Our contributions are as follows. We provide a framework for performing policy improvement that is robust in the face of unobserved confounding by using a robust optimization formulation. Our framework allows for the specification of data-driven uncertainty sets based on a sensitivity parameter describing a pointwise bound on the odds ratio between true and observed propensities as well as uncertainty sets with a global budget-of-uncertainty parameter. We prove a uniform law that leads to an appealing improvement guarantee that shows that, up to vanishing factors that depend on the complexity of the policy class, our approach will not do worse than the baseline and, moreover, will do better, as can be easily validated by simply evaluating the objective value of our optimization problem. Leveraging the structure of our optimization problem and characterizing the inner subproblem, we provide a set of efficient algorithms for performing robust policy optimization over parametrized policy classes and over decision trees. We assess performance on a synthetic example that illustrates the benefits of our approach and the effect of the uncertainty parameters. We then study a large clinical dataset on the treatment of acute ischaemic stroke, the results of which suggest only aspirin and not heparin should be used for treatment. We show how standard approaches that try to learn more personalized policies for treatment can actually introduce harm by over-intervening with aggressive heparin treatments and introducing adverse effects, while our approach avoids this and learns to intervene with aggressive treatments only in the most severe cases, leading to a personalized treatment policy that improves upon the recommended standard of only using aspirin.
We first begin by introducing a case study of the parallel Women's Health Initiative (WHI) clinical trial and observational study in order to illustrate how confounding factors can lead to wide clinical discrepancies in the conclusions from observational data or a randomized trial. By constructing a synthetic model inspired by this case, we demonstrate how these confounding factors can detrimentally affect policy learning and what can be gained from robustness to confounding.
2 Women's Health Initiative: An illustrative case of the perils of learning to intervene from confounded data
Hormone replacement therapy (HRT) is an effective treatment strategy for vasomotor symptoms of menopause, such as hot flashes and night sweats. The clinical practice of prescribing HRT in menopause was driven in part by observational epidemiological studies that showed effective reduction of menopausal vasomotor symptoms as well as a protective benefit against coronary heart disease (CHD) (Pedersen and Ottesen 2003) . The results, however, were later repudiated by more evidence from the WHI clinical trial. In fact, while the observational study suggested a protective benefit of HRT against CHD, showing a 40-50% reduction in CHD incidence, the HRT arm of the clinical trial had to be stopped early due to a dangerously elevated incidence of CHD (Prentice et al. 2005) . After the WHI study, the new evidence that arose not only dramatically changed the standard of care, spurring an 80% reduction in the prescription of HRT, but also sparked a broader methodological debate about the clinical credibility of observational studies (Lawlor et al. 2004 ). WHI's study design included a clinical trial enrolling n = 16,608 women with intact uteri to study combined estrogen-plus-progestin HRT, a separate clinical trial enrolling n = 10,739 women with prior hysterectomy (without a uterus) to study a regimen of estrogen alone, in parallel to an observational study of n = 93,726 women.
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The progestin-plus-estrogen arm was stopped prematurely due to preliminary findings suggesting that significant risks for increased rates of breast cancer, CHD, stroke, and pulmonary embolism outweighed benefits. The estrogen-only arm was also stopped shortly afterwards. In the immediate aftermath of the trial results, researchers proposed differing re-analyses and explanations to reconcile the different findings from the clinical trial and observational study. Many of the explanations, as we review below, suggested a variety of confounding factors that led self-selection to obfuscate the actual isolated risks of the treatment alone. Thus, the case of HRT is a clear example of an intervention policy learned from observational data that led to unwarranted harm due to unaccounted-for confounding.
The observational study may have been confounded by plausible, well-recognized confounding phenomena, healthy user bias and confounding by indication, which challenge the validity of all epidemiological research from observational health databases and which may induce correlation in either direction between treatment selection and outcomes (Brookhart et al. 1 Specifically, estrogens consisted of conjugated equine estrogens (CEE) and progestins of medroxyprogesterone acetate (MPA). 2010). Such possible confounding factors arise naturally from the structure of healthcare data in which physicians determined treatment assignment to manage health outcomes in the first place. Much discussion attributes confounding in the study to healthy user bias arising from differing lifestyle factors in the population of women self-selecting into HRT, where lifestyle factors such as general health-seeking behaviors, such as exercise or maintaining heart-healthy diets, are correlated with better expected outcomes related to CHD on average. These general health-seeking and health-promoting behaviors tend to reduce artherosclerotic risk and risk of CHDs, but are unobserved lifestyle factors that are confounders for self-enrollment into HRT. Conversely, the study may have also been confounded by indication or severity, where the presence of clinical activities such as prescription of HRT is correlated with, or indicates, greater initial symptom severity, which may lead to attenuation in the perceived reduction in vasomotor symptoms.
On the one hand, the trial suggested serious risks of widespread HRT treatment that may have been misinformed by confounded observational studies, but on the other, as has been pointed out only later (Vogel 2017) , it also suggested that the risk-benefit consideration was different for older and younger women and that younger women may be safely treated. Specifically, Manson et al. (2013b) , Rossouw et al. (2013) note that while the trial data definitively provide evidence against the net benefits of HRT (administered via the WHI-proprietary treatment regimen) for prevention of chronic disease, the evidence from WHI for a standard HRT regimen of estrogen alone was inconclusive to rule out possible cardiovascular risk reductions for women treated closer to menopause onset (<10 years) with prior hysterectomy. This may have been left unnoticed at first because since the trial itself did not include many younger women for whom treatment could be beneficial.
The time-based heterogeneity of treatment effect may arise from clinical explanations that estrogen may slow down early artherosclerosis, the formation of plaques in arteries, and have favorable endothelial effects in women with recent onset in menopause. However, unlike other options such as statin therapies which help prevent CHD at any age and stage of disease, HRT may actually worsen already-established plaques and thus increase the frequency of coronary events (see Manson et al. 2013a , Rossouw et al. 2013 . These differing risk profiles were also observed in the observational study, although the risks may have been underestimated across the board. For all women, the improvement of vasomotor symptoms was significant, but ultimately the greater risks of adverse events outweigh the clinical benefits for older women. Modern clinical guidelines, included in Bakour and Williamson (2015) , recognize that "when HRT is individually tailored women gain maximum advantages and the risks are minimised." Therefore, the clinically relevant policy learning question is determining the optimal tailoring of targeted treatments such that the clinical benefits of HRT do not also incur substantial increase in risk of CHD and other adverse events. Specifically, consider the situation faced originally when only observational data were available. Recognizing the potential presence of confounding, how could one analyze the data to infer a targeted treatment policy that would not introduce any additional harm relative to never treating with HRT, while benefiting the individuals that could truly benefit from HRT? This is the question we explore next in a simplified synthetic model inspired by the case of WHI and HRT.
A Simple Model Inspired by WHI to Illustrate Confounding in Policy Learning
We consider a simple synthetic model to illustrate the problem of confounded policy learning, inspired by the confounding and treatment effect interactions at play in the case of the WHI observational study on HRT. We will also use this opportunity to introduce our notation and framework, which we will again summarize in Sec. 3. Suppose that, for each individual, we have baseline data consisting of X 2 X , an observed variable in the space X (usually R d ) upon which we want to personalize treatment. Specifically, we want to assess and/or learn a policy ⇡ : X ! [0, 1] that, given an individual with covariates X, would treat the individual with probability ⇡(X). Let us identify treatment with +1 and no treatment (control) with 1. Then treatment by policy ⇡ is a random variable
. Usually, X would contain a rich set of features that can help drive precise and effective treatment, as in the case of the real clinical dataset we consider in Sec. 7.2. In the example here, for simplicity, we will consider just a univariate uniform variable, X ⇠ Unif [ 1, 1] , that represents age (normalized to lie in X = [ 1, 1]) at consideration for treatment with HRT. As discussed in the previous section, age is considered a key factor affecting both the benefits and the risks of HRT and should therefore potentially drive the decision of whether or not to treat.
Each individual, at the time of consideration for treatment, is associated with a baseline variable X as well as the potential outcomes, Y (1), Y ( 1) 2 R, indexed by each possible treatment value, that denote the total risk plus negative benefits the individual would experience if she were to be treated with HRT and if she were not to be treated, respectively. In particular, Y (1) also includes any added risk, toxicity, and/or costs of intervention. The difference in potential outcomes Y (1) Y ( 1) is positive whenever an individual would be harmed by HRT and negative whenever benefited. For example, Y (1) Y ( 1) would be very positive if HRT led to heart disease that would not have otherwise occurred and it would be somewhat negative if HRT helped reduce menopausal symptoms without causing additional adverse events. The potential outcomes represent only what would happen if we were to treat or not treat. Obviously, both potential outcomes Y (1), Y ( 1) can never be simultaneously observed for any one individual, a fundamental limitation often referred to as the fundamental problem of causal inference (Holland 1986) .
For the purpose of illustration, we construct a hypothetical model specifying the relationships between these variables. We suppose that, for t 2 { 1, +1},
where sign(x) = 1 2I [x  0] and ✏ 2 { 1, +1} is a random disturbance independent of X with P (✏ = +1) = ✓ where ✓ is a parameter. The difference Y (1) Y ( 1) = 2X +3.6 sign(X)✏ has two terms. The first term, 2X, corresponds to baseline heterogeneous biological effects, where HRT is protective for younger women and but harmful for older women. The noise term, 1.8(1 + t sign(X))✏, encapsulates the secondary effects observed in the WHI studies, which may plausibly affect outcomes in either beneficial or harmful directions differently for younger and older women.
When assessing a hypothetical treatment assignment policy such as, e.g., ⇡(X) = I[X < 0] (treat only young women), from an epidemiological public health perspective, we are primarily interested in the average policy value,
The policy value is the population average outcome induced by policy ⇡. The policy value can also be written as
The function ⌧ (x) is known as the conditional average treatment effect (CATE). If CATE were known, then it would be clearly optimal to treat a woman of age x whenever ⌧ (x) < 0 and otherwise not to treat. Often, the goal of policy evaluation may actually be to assess the benefits or harms of a candidate policy ⇡ relative to current procedure or the standard of care, which we consider to be some baseline policy ⇡ 0 . For example, for studying HRT based on observational data before the trial, given the lack of existing clinical trial evidence or wellstudied biological mechanisms to support the broad use of HRT, the baseline policy is naturally ⇡ 0 (X) = 0, assigning the control treatment to all. Thus, we may be interested in assessing the policy regret incurred by candidate HRT treatment policy ⇡(X) relative to the population outcomes induced by the standard of care,
This regret is positive whenever ⇡ would introduce net harm if it were to replace ⇡ 0 , and it is negative whenever ⇡ introduces net good. In our example, under eq. (1), we have that
suggesting that the optimal policy depends on the parameter ✓.
As mentioned above, in actual clinical data, Y ( 1), Y (1) are never both observed simultaneously. Instead, for each individual in the data, we would observe a variable T 2 { 1, 1}, indicating whether the individual was treated (T = 1) or not (T = 1), as well as the observed outcome for that individual Y 2 R such that the observed outcome corresponds to the potential outcome of the observed treatment, Y = Y (T ).
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The data is assumed to consist of independent and identically distributed (IID) draws, X i , T i , Y i , of X, T, Y for i = 1, . . . , n. Thus, the observed-data generating process is characterized by the joint distribution of X, T, Y , and this distribution is the most we could hope to learn from any amount of data. If, for different settings of (potentially infinite) parameters, a quantity that depends on the joint distribution of X, T, Y (1), Y ( 1) (such as CATE) can take two different values while the the joint distribution of X, T, Y remains the same, then we say that this quantity is not identifiable. Alternatively, we say that those two values are observationally equivalent since they cannot be distinguished from one another based on the observations we make, as the data we see will still have the same distribution.
We now consider the specific confounding structure of the WHI observational study. In an observational study, T may be correlated with the potential outcomes so that those that self-selected to participate in treatment may have higher or lower overall outcomes. Similarly plausible scenarios of unobserved confounding could have been present in the WHI study: confounding by healthy lifestyle factors, which improves outcomes regardless of treatment, or confounding by severity, which attenuates the perceived alleviation in vasomotor symptoms.
The equation Y = Y (T ) captures two important features. One is that the observed outcomes are consistent with the hypothetical potential outcomes. Another is that the outcome of an individual only depends on the treatment assignment of that individual and there is no interference between units. This two assumptions together are also known as the stable unit treatment value assumption (Rubin 1980 ). Suppose in particular that we have that
which is in (0, 1) for all ✓ 2 (1/8, 7/8). In our model, laid out in eqs. (1) and (3), we have only one parameter: ✓. Let us assume that it can take any value ✓ 2 ⇥ = [1/4, 3/4]. The parameter ✓ affects CATE, as seen in eq. (2). We next show that this parameter does not affect the observed data and it is therefore not identifiable. Consequently neither is CATE.
(1) and (3). Then the joint distribution of X, T, Y is well defined and independent of the value of ✓ for any ✓ 2 ⇥. That is, all the values of ✓ 2 ⇥ are observationally equivalent.
This shows that, without affecting the data we would see, CATE could actually be any function in eq. (2) for any ✓ 2 ⇥. For two examples, ✓ = 1/2 gives rise to ⌧ 0 (x) = 2x and ✓ = 13/36 gives rise to ⌧ 1 (x) = 2x sign(x). If we were to ignore the potential confounding factors, we would simply estimate CATE using a predictive analysis of outcomes in each treatment group:
If indeed there was no unobserved confounding then, once we condition on X, treatment assignment T would be mean-independent of the potential outcomes
If this were the case then⌧ (x) would be guaranteed to be equal to CATE. In fact, with or without unobserved confounding, Eq. (4) is precisely what is estimated by any method that assumes unconfoundedness, including, e.g., Shalit et al. (2017) , Wager and Athey (2017b) or a direct regression analysis on eq. (4). We plot⌧ in Fig. 1 (dashed line). Since it is equal to ⌧ 0 , it is also a feasible function in eq. (2). Now, suppose we were to use this observational estimate as our guess for CATE and make our treatment decisions correspondingly. This would suggest that we should treat all women of ages x < 0 and not treat the rest. If indeed ⌧ (x) = 2x then this would lead to a regret of 1 compared to never treat, meaning we would be doing net good by targeting younger women for treatment. However, since CATE can actually be any function in eq. (2) for any ✓ 2 ⇥, the true regret of this policy can be as bad as 0.8, meaning that we could be introducing a significant amount of net harm, possibly causing higher rates of adverse events such as heart disease and cancer because of hasty predictive analysis of observational data leading to overeager intervention. This highlights the potential pitfalls of unchecked policy learning and poses a critical barrier to personalizing medical treatments based on EMRs, where confounding is sure to be a factor.
This clearly shows that it is indeed not clear that women of ages x < 0 would necessarily be helped by HRT: the value of CATE could be positive. But this also clearly shows that women of ages x < 0.9 do necessarily benefit from treatment: for them, all possible CATEs are bounded below zero. Here, this suggest a much more cautious intervention strategy, where we treat only women of ages x < 0.9 and not treat the rest. Over all possible values of ✓ 2 ⇥, this will have regret no worse than 0.1 relative to never treat, meaning that we are assured some net benefit. This highlights that even if we do not know the true value of CATE, we might still be able to identify subgroups of the population that would be ensured benefit from intervention.
Surprisingly, we could actually do better than that by more carefully addressing the policy learning problem rather than viewing this as just a predictive analysis (with identification bounds). Suppose we were searching over depth-2 tree-based policies, that is, a policy that can be written as two nested queries about the value of x being above or below a threshold and assigning the same value ⇡(x) to all values in a leaf node. Consider such a policy which treats women of ages
Over all possible values of ✓ 2 ⇥, this policy will have regret no worse than 0.5 relative to never treat, which is significantly better than the above approach. This policy in fact turns out to be minimax optimal for this problem, that is, it minimizes the maximal regret. This is exactly the approach we will take in this paper: search over a restricted policy class to find the policy that minimizes the maximal value that regret can take, given what can and cannot be identified from the data. This directly targets the policy learning problem (rather than addressing the predictive problem) while carefully accounting for potential confounding and is able to identify a policy that, despite potential confounding in the data, is still assured to never introduce harm and in fact bestow a significant net benefit whenever possible.
In the following, rather than this simplistic one-parameter model, we will use a more natural and flexible approach to characterize the potential unobserved confounding, known as the Rosenbaum model. Before proceeding to develop our particular method, we review some of the relevant background and the literature upon which we draw.
Problem Statement and Preliminaries
We first summarize the setup. We consider policy learning from observational data consisting of tuples of random variables {(X i , T i , Y i ) : i = 1, . . . , n}, comprising of covariates X i 2 X , assigned treatment T i 2 { 1, 1}, and real-valued outcomes Y i 2 R. We let Y i ( 1), Y i (1) denote the potential outcomes of applying treatment 1 and 1, respectively. We use the convention that the outcomes Y i corresponds to losses so that lower outcomes are better. We consider evaluating and learning a (potentially randomized) policy mapping covariates to the probability of assigning treatment, ⇡ : X ! [0, 1], where we focus on a policy class ⇡ 2 F of restricted complexity. Examples include linear policies
, or decision trees of a bounded depth, which assign any probability to each leaf of the tree. Define policy value of ⇡ as
Without loss of generality, we assume that there is an additional (but unobserved) covariate U i such that unconfoundedness would hold if we were to control for both X i and
, and we define e(X i , U i ) = P (T = 1 | X i , U i ). This is without loss of generality as it holds for
). Equivalently, we can treat the data as collected under an unknown logging policy that based its assignment on both X i and U i and that assigned T i = 1 with probability e(X i , U i ). Here, e(X i , U i ) is precisely the true propensity score of unit i. Since we do not have access to U i in our data, these too are unobserved, and instead we only have access to nominal propensitiesê(X i ) = P (T = 1 | X i ). These do not account for the potential unobserved confounding. We assume that these are part of the data. Indeed, they can be estimated directly from the data using a probabilistic classification model such as logistic regression or a neural network. For compactness, we denoteê
Related Work
Our work builds upon several strands of literatures, notably policy learning from observational data as well as sensitivity analysis in causal inference.
Causal inference for personalization from observational data under unconfoundedness.
The key difficulty in learning interventional effects from observational data is that the outcome Y i (T i ) is only observed for the treatment actually administered historically to the unit, T i , whose assignment can itself be correlated with the potential outcomes, obfuscating differences in them. Since the data is observational and the treatment assignment procedure was not under the control of the experimenter, the distribution of covariates may be systematically different between treatment and control groups due to self selection of the individuals into treatments, medical imperatives trading off treatment risk vs. patient severity, or business imperatives to offer discounts or target advertising not completely at random. Thus, the systematic differences in covariates in the population P (X = x, U = u | T = 1) , P (X = x, U = u | T = 1), also known as covariate shift, make the treated and untreated populations incomparable for the purpose of assessing effect.
When all covariates needed to ensure unconfoundedness are assumed to be observed, i.e, U is null and unconfoundedness holds with respect to the observed
, then a variety of approaches for learning personalized intervention policies that maximize causal effect have been proposed. These fall under regression-based strategies (Bertsimas et al. 2016, Qian and Murphy 2011) , reweightingbased strategies (Beygelzimer and Langford 2009 , Kallus 2017a , Kitagawa and Tetenov 2018 , Swaminathan and Joachims 2015b , or doubly robust combinations thereof (Dudik et al. 2014, Wager and Athey 2017a) . Regression-based strategies estimate the conditional average treatment effect (CATE), E[Y (1) Y ( 1) | X], either directly or by differencing two regressions estimated separately on the treated and untreated populations since, under
These estimates are either used directly to treat by comparing it to zero (known as direct comparison) or to score policies and pick the best in a restricted class (know as the direct method ). If the CATE function is ill-specified, we are not guaranteed to find the best policy, even if the class is amenable to the estimation method (e.g., the best linear policy does not arise from comparing the best linear CATE estimator to zero). Of course, as we have seen in Sec. 2.1, without unconfoundedness, CATE is not identifiable from the data (parametrically or non-parametrically) and these methods have no guarantees.
Reweighting-based strategies use inverse propensity weighting (IPW) (Beygelzimer and Langford 2009 , Kallus 2017a , Kitagawa and Tetenov 2018 , Swaminathan and Joachims 2015b or covariate-balancing weights (Kallus 2017b ) to change measure from the distribution induced by a historical logging policy to that induced by any new policy ⇡. Specifically, these methods use the fact (Li et al. 2011 
This estimator is often centered with respect toV IPW (⇡ 0 ) for ⇡ 0 (x) = 1/2 since then, for deterministic policies, each term is either plus or minus of Y i /ê T i (X i ), depending on whether
IPW (⇡) for deterministic policies can be phrased as a weighted classification problem (Beygelzimer and Langford 2009) . Dudik et al. (2014) suggest to augment eq. (5) by using the doubly-robust estimator (Robins et al. 1994) , which centers the outcomes using a regression estimate. Wager and Athey (2017a) show that since this estimate is semiparametrically efficient when using cross-fold fitting, as shown by Chernozhukov et al. (2016) , this leads to better regret bounds. Since dividing by propensities can lead to extreme weights and high variance estimates, clipping the probabilities are typically necessary for good performance Joachims 2015a, Wang et al. 2017) or the use of weights that directly optimize for balance (Kallus 2017b) . With or without any of those fixes, if there are unobserved confounders, then, as we have seen in Sec. 2.1, neither a policy's value not the optimal policy are identifiable, and any of these methods may lead to learned policies that introduce more harm than good.
Under unconfoundedness, such reweighting-based methods are notable for being able to find best-in-class policies regardless of specification of an outcome model (or with outcome models learned at sub-parametric rates; Wager and Athey 2017a). Specifically, they focus directly on the policy learning problem rather than a prediction problem and on finding a policy that performs as the best in a given class. This leads to strong generalization guarantees (Kallus 2017b , Kitagawa and Tetenov 2018 , Wager and Athey 2017a and can also allow one to incorporate domain-specific constraints that favor simple prescriptive decision policies that are interpretable, implementable, and/or satisfy operational constraints, such as scorecards or decision-trees (Ustun and Rudin 2015) . These constraints and approaches for training optimal constrained policies can be composed directly with the policy optimization problem by restricting the policy class. Because of these unique properties, our approach will also be based on a reweighting approach that directly optimizes a policy rather than a predictor. Our approach additionally, and crucially, handles the commonplace yet detrimental issue of unobserved confounding.
Policy improvement. A separate literature within reinforcement learning, unrelated to causal inference, considers the idea of safe policy improvement by forming an uncertainty set around the presumed unknown transition probabilities between states as in Thomas et al. (2015) or forming a trust region for safe policy exploration via concentration inequalities on estimates of policy risk as in Petrik et al. (2016) . None of these consider the issue of confounding or observational data. This general approach of safely improving upon another policy using a robust or minimax formulation is related to, and inspires the name of, our method.
Sensitivity analysis. Sensitivity analysis in causal inference tests the robustness of qualitative conclusions (usually, that there is or is not an effect) made based on observational data to model specification and/or to assumptions, such as unconfoundedness. Some approaches for assessing unconfoundedness require auxiliary data or additional structural assumptions, which we do not assume here (Imbens and Rubin 2015) . Other approaches consider how large confounding must be to invalidate the conclusions using the Rosenbaum model (Rosenbaum 2002) . Our approach uses the Rosenbaum model and focuses on the implications for personalized treatment decisions.
The Rosenbaum model for sensitivity analysis assesses the robustness of randomization inference to the presence of unobserved confounding by considering a uniform bound on the odds ratio between true and nominal propensities, motivated by a logistic specification (Rosenbaum 2002) . Such a restriction corresponds to a model where the odds-ratio for treatment between two units with the same covariates X i = X j , which differs due to the units' different values U i , U j for the unobserved confounder, is U i U j , where is a parameter and U i , U j 2 [0, 1] may be arbitrary. The value of can be calibrated against the discrepancies induced by omitting observed variables; then determining can be phrased in terms of whether one thinks one has omitted a variable that could have increased or decreased the probability of treatment by as much as, say, gender or age can in the observed data (Hsu and Small 2013) . The general approach taken by sensitivity analyses in this model is to use randomization inference to assess how big the p-value on the hypothesis of no effect can be depending on the value of so that such binary conclusions can be couched in terms of the level of unobserved confounding (Fogarty and Small 2016 , Hasegawa and Small 2017 , Rosenbaum 2002 .
In the sampling literature, the Hájek estimator for population mean (Hájek 1971 ) is an extension of the classic Horvitz-Thompson estimator (Horvitz and Thompson 1952) that adds weight normalization. The objective of the minimax game we define between policy optimizer and possible confounding is a Hájek estimator for the policy value. Aronow and Lee (2012) derive sharp bounds on the estimator arising from a uniform bound on the sampling weights, showing a closed-form for the solution for a uniform bound on the sampling probabilities. Zhao et al. (2017) consider bounds on the Hájek estimator, but impose a parametric model on the treatment assignment probability. Miratrix et al. (2018) consider tightening the bounds from the Hájek estimator by adding shape constraints, such as log-concavity, on the cumulative distribution of outcomes.
Robust policy evaluation and improvement
We now present our framework for confounding-robust policy improvement. Our approach minimizes a bound on policy regret against a specified baseline policy ⇡ 0 , R ⇡ 0 (⇡) = V (⇡) V (⇡ 0 ). Our bound is achieved by maximizing a reweighting-based regret estimate over an uncertainty set around the nominal propensities. This ensures that we cannot do any worse than ⇡ 0 and may in fact do better, even if the data is confounded.
The baseline policy ⇡ 0 can be any fixed policy that we want to make sure not to do worse than or deviate from unnecessarily. This is usually the current standard of care, established from prior evidence, and we would not want any algorithmic solution to personalization to introduce any harm relative to current standards. Generally, this is the policy that always assigns control, ⇡ 0 (x) = 0. Alternatively, if reliable clinical guidelines exist for some limited personalization, then p 0 (x) represent the non-constant function that encodes these. In an intervention-agnostic extreme, ⇡ 0 can also be the complete randomization policy, ⇡ 0 (x) = 1/2.
Confounding-robust policy learning by optimizing minimax regret
If we had oracle access to the true inverse propensities
we could form the correct IPW estimate by replacing nominal with true propensities in eq. (5). We may go a step further and, recognizing that E[W 
It follows by Slutsky's theorem that these estimates remain consistent (if we know W ⇤ i ). Note that had we known W ⇤ i , both the normalization and choice of ⇡ 0 would have amounted to constant shifts and scales toR ⇤ ⇡ 0 (⇡) that would not have changed which policy ⇡ minimizes the regret estimate and is therefore learned. This will not be true of our bound, where both the normalization and the choice of ⇡ 0 will be material to the success of the method.
Since the oracle weights W ⇤ i are unknown, we instead minimize the worst-case possible value of our regret estimate, by ranging over the space of possible values for e T i (X i , U i ) that are consistent with the observed data and our assumptions about the confounded data-generating process. Specifically, our model restricts the extent to which unobserved confounding may affect assignment probabilities. We first consider an uncertainty set motivated by the oddsratio characterization in Rosenbaum (2002) , which restricts how far the weights can vary pointwise from the nominal propensities. Given a bound > 1, the odds-ratio restriction on e(x, u) is that it satisfy the following inequalities 1 
(1 ê(x))e(x, u) e(x)(1 e(x, u))  .
This restriction is motivated by (but more general than) considering an additive model where e(x, u) = (g(x) + h(u)), g is any function and |h(u)|  log( ). The choice of can be calibrated using, e.g., the method of Hsu and Small (2013) .
Note that, by symmetry, eq. (6) can equivalently be written in terms of the functionŝ e T (x), e T (x, u). Therefore, we see that the restriction in eq. (6) immediately leads to the following uncertainty set for the true inverse propensity weights of each unit, W ⇤ i = 1/e T i (X i , U i ), centered around the nominal inverse propensity weights,Ŵ i = 1/ê T i (X i ), that do not account for all confounding:
The corresponding bound on the empirical regret Hájek estimator is R ⇡ 0 (⇡; U n ), where for any U ⇢ R n + we define
Note that R ⇡ 0 (⇡; U ) = R ⇡ 0 (⇡; S t>0 (tU )) for any U ⇢ R n + so that any uncertainty set can be made to also include all its scalings without inflating the objective, eq. (8).
We then choose the policy ⇡ in our class F to minimize this regret bound, i.e., ⇡(F, U n , ⇡ 0 ), where
In particular, for our worst-case regret objective R ⇡ 0 (⇡; U n ), weight normalization is crucial for only enforcing robustness against consequential realizations of confounding that affect the relative weighting of patient outcomes. Any mode of the confounding that affects all weights similarly should have no effect on policy choice. Moreover, even if we do not know U i or W ⇤ i , we know that they must satisfy E[W ⇤ i ] = 2, so any realization that violates that is impossible. Moreover, different baseline policies ⇡ 0 structurally change the solution to the adversarial subproblem by shifting the contribution of the loss term Y i T i (⇡(X i ) ⇡ 0 ) to emphasize improvement upon different baselines. In particular, if the baseline policy is in the policy class F, it already achieves 0 regret; thus, minimizing regret necessitates learning a policy that must offer some benefits in terms of decreased loss regardless of confounding.
Budgeted uncertainty sets to address "local" confounding
The above uncertainty set, eq. (7), might be pessimistic in ensuring robustness against every possible worst-case realization of unobserved confounding for each unit, whereas concerns about unobserved confounding might be limited to subgroup risk factors or outliers. For the Rosenbaum model in hypothesis testing, this has also been recognized by Fogarty and Hasegawa (2017) , Hasegawa and Small (2017) in the context of classic sensitivity analysis. Motivated by this, we next consider an alternative uncertainty set, where we fix a budget of uncertainty ⇤ for how much the weights can diverge from the nominal inverse propensity weights in total. Specifically, we construct the uncertainty set
When plugged into eq. (9), this provides an alternative policy choice criterion that is less conservative. To make the choice of parameters easier, we suggest to calibrate ⇤ as a fraction, ⇢ < 1, of the total deviation already allowed by U n . Specifically,
. This is the approach we take in our empirical investigation.
The Improvement Guarantee
Before discussing how we actually algorithmically compute ⇡ in eq. (9), we next prove a statistical guarantee about it that shows that, if we appropriately bounded the potential hidden confounding, then the optimal value of our worst-case empirical regret objective, that is, that achieved by ⇡, is asymptotically an upper bound on the true population regret of ⇡. The result is in fact a finite-sample result that gives precisely a bound on how much the latter might exceed the former due to finite-sample errors -terms that vanish as n grows, even if there is unobserved confounding. On the one hand, since our objective is necessarily non-positive if ⇡ 0 2 F, this says we will never do worse (up to vanishing terms). On the other hand, if our objective is sufficiently negative, which we can check by just evaluating it, then we are assured some strict improvement. Our result is generic for both the uncertainty sets we defined above, U n and U ,⇤ n . Our upper bound depends on the flexibility of our policy class. It is critical that we search over a flexible but not completely unrestricted class in order to get an improvement. We express the flexibility of F using the notion of Vapnik-Chervonenkis (VC) dimension (Vapnik 1998 ), which we define below.
3 Definition 1. The VC dimension of F is the largest number v 2 N such that there exists x 1 , . . . , x v 2 X with
If eq. (10) holds then we say F shatters x 1 , . . . , x v , which means that any subset of the points belong exclusively to some sublevel set of some ⇡ 2 F and its complement to the corresponding superlevel set. The more complex a class is, the larger the point sets it can shatter. Thus, VC dimension is a natural expression of function class complexity or flexibility. If X = R d , then the VC dimension of both the linear policies and logistic policies is d + 1. For binary decision trees of depth no more than D, if each inner node can be a query x i  ✓ for any i = 1, . . . , d and ✓ = ✓ i1 , . . . , ✓ iK and each leaf node is assigned its own probability, then the VC dimension of this class is at most 2 D log 2 (dK + 2). In general, all policy classes we consider have a bounded VC dimension.
Our bound also requires that outcomes have nice tails; specifically, subgaussian tails.
Definition 2. A random variable Z with EZ = 0 is said to be subgaussian with parameter 2 if for all 2 R we have E exp( Z)  exp( 2 2 /2).
In particular, a normal random variable N (0,
2 ) is subgaussian with parameter 2 and a zero-mean random variable bounded in [ B, B] is subgaussian with parameter B 2 . Our guarantee is then as follows:
µ is subgaussian with parameter 2 where µ = EY , and that the VC dimension of ⇧ is no more than v 2 N. Then for any > 0 such that n max
, we have that with probability at least 1 ,
In particular, if we let ⇡ = ⇡(F, U , ⇡ 0 ) be as in eq. (9) then eq. (11) holds for ⇡ since it holds uniformly. This is nice because ⇡ minimizes the right hand side, which bounds its true regret. Moreover, the second term on the right hand side of eq. (11) vanishes as n ! 1 at a rate of O(n 1/2 ), regardless of any unobserved confounding. So, if the objective R ⇡ 0 (⇡; U ) is negative, we are (almost) assured of getting some improvement on ⇡ 0 (up to O(n 1/2 ) errors). At the same time, so long as ⇡ 0 2 ⇧, the objective is necessarily non-positive, R ⇡ 0 (⇡; U )  0, so we are also (almost) assured of doing no worse than ⇡ 0 (up to O(n 1/2 ) errors). All this, without ever being able to identify or estimate any population effect or any one individual-level effect, due to the unobserved confounding. Thus, Theorem 1 exactly captures the special appeal of our approach.
Algorithms for Optimizing Robust Policies
We next discuss how to algorithmically solve the policy optimization problem in eq. (9) and actually find the confounding-robust policy, ⇡. The solution method will depend on the policy class we consider optimizing over; we consider two cases. One case is differentiable parametrized policy classes, F = {⇡( · ; ✓) : ✓ 2 ⇥} such that ⇡(x; ✓) is differentiable with respect to ✓, such as logistic policies. In this case we will use subgradient descent to find the robust policy. The other case is decision-tree based policies, where we will use mixed-integer optimization. In both cases, our solution will depend on a characterization of the inner worst-case regret subproblem.
We next discuss how to solve the worst-case regret subproblem for a fixed policy, which we will then use to develop our algorithms.
Dual Formulation of Worst-Case Regret
The minimization in eq. (9) involves an inner supremum, namely R ⇡ 0 (⇡; U n ). Moreover, this supremum over weights W does not on the face of it appear to be a convex problem. However, a standard transformation will reveal its convexity. We next proceed to characterize this supremum, formulate it as a linear program, and, by dualizing it, provide an efficient line-search procedure for finding the pessimal weights.
For compactness and generality, we address the optimization problem Q(r; U n ) parameterized by an arbitrary reward vector r 2 R n , where
To recover R ⇡ 0 (⇡; U ), we would simply set r i = 2(⇡(
First we consider U n . Since U n involves only linear constraints on W , eq. (12) for U = U n is a linear fractional program. We can reformulate it as a linear program by applying the Charnes-Cooper transformation (Charnes and Cooper 1962) , requiring weights to sum to 1, and rescaling the pointwise bounds by a nonnegative scale factor t. We obtain the following equivalent linear program in normalized weight variables w:
The dual problem to eq. (13) has dual variables 2 R for the weight normalization constraint and u, v 2 R n + for the lower bound and upper bound constraints on weights, respectively. By linear programming duality, we then have that
We use this to show that solving the inner subproblem requires only sorting the data and a ternary search to optimize a unimodal function. This generalizes the result of Aronow and Lee (2012) for arbitrary pointwise bounds on the weights. Crucially, the algorithmically efficient solution will allow for faster subproblem solutions when optimizing our regret bound over policies in a given policy classes.
Theorem 2 (Normalized optimization solution). Let (i) denote the ordering such that
, where k ⇤ = inf{k = 1, . . . , n+1 : (k) < (k 1)} and
Moreover, (k) is a discrete concave unimodal function.
Next we consider Q(r; U ,⇤ n ). Write an extended formulation for U ,⇤ n using only linear constraints:
This immediately shows that Q(r; U ,⇤ n ) remains a fractional linear program. Indeed, a similar Charnes-Cooper transformation as used above yields a non-fractional linear programming formulation:
The corresponding dual problem is:
As Q(r; U ,⇤ n ) remains a linear program, we can easily solve it using off-the-shelf solvers, even if it does not admit as simple of a solution as Q(r; U n ) does.
Optimizing Parametric Policies
We next consider the case where F = {⇡(·; ✓) : ✓ 2 ⇥}, ⇥ is convex (usually ⇥ = R m ), and ⇡(x; ✓) is differentiable with respect to ✓. We suppose that r ✓ ⇡(x; ✓) is given as an evaluation oracle. An example is logistic policies where ⇡(X; ↵, ) = (↵ + | X) and ⇥ = R
d+1
. Since 0 (z) = (z)(1 (z)), evaluating derivatives is simple. Our method follows a parametric optimization approach (Still 2018) . Note that Q(r; U ) is convex in r since it is a maximum over linear functions in r. Correspondingly, its subdifferential at r is given by the argmax set:
. Although F (✓) := R ⇡ 0 (⇡(·; ✓); U ) may not be convex in ✓, this suggests a subgradient descent approach. Let
Note that whenever @ r Q(r(✓); U ) = {W/ P n i=1 W i } is a singleton then g(✓; W ) is in fact a gradient of F (✓). , 2 arg max
Algorithm 1 Parametric Subgradient Descent
. Solve inner subproblem for ✓ t 5:
. Move in subgradient direction 6: return ✓ arg mint lt At each step, our algorithm starts with a current value of ✓, then proceeds by finding the weights W that realize R ⇡ 0 (⇡(· ; ✓) by using an efficient method as in the previous section, and then takes a step in the direction of g(✓; W ). Using this method, we can optimize policies over both the unbudgeted uncertainty set U n and the budgeted uncertainty set U ,⇤ n . Because descent is not always guaranteed at each step, at the end, we return the value of ✓ that corresponds to the best objective value seen so far. Our method is summarized in Alg. 1.
Optimal Confounding-Robust Trees
We next consider the function class consisting of axis-aligned decision tree policies where each leaf is assigned a constant probability of treatment. Decision tree policies are advantageous due to their simplicity and interpretability. Our optimal confounding-robust tree (OCRT) presented below determines the best confounding-robust decision tree via global optimization using mixed-integer optimization. Our approach is to combine the dual linear program formulation of R ⇡ 0 (⇡; U n ) in eq. (14) with a mixed-integer formulation of this class of decision trees, following the formulation of Bertsimas and Dunn (2017) , along with a special heuristic to find a good warm start.
A decision tree (with maximal splits) of a fixed depth D can be represented by an array labeled by a set of nodes, split into a set of branching nodes T B and leaf nodes T L . The space of decision tree policies is parametrized by ⇥ = {{a t , b t } t2T B , {c t } t2T L }, where a t , b t 2 R p parametrize the split at branching node t, which directs units to the left branch if a | x < b, and to the right branch otherwise. The policy assignment probability is parametrized by c t 2 [0, 1] for t 2 T L . We consider axis-aligned splits such that a t is a unit vector.
We let the binary assignment variables z it track assignment of data points i to leaves t 2 T L subject to the requirement that every instance is assigned to a leaf node according to the results of axis-aligned splits a | t x < b t , for splits occurring at t 2 T B branch nodes. The binary variables d t track whether a split occurs at node t 2 T B . The binary variable l t tracks whether a leaf is empty or not. The policy optimization determines both the partitions of the covariates governing assignment to terminal leaf nodes and the variables c t for t 2 T L governing probability of treatment assignment in the leaf nodes. We denote par(t) as the parent of node t, A(t) as the set of all ancestors of node t, and the subsets A L (t)[A R (t) = A(t) denote the sets of ancestor nodes where the instance was split to the left or right, respectively. In this section, we assume that the covariates are rescaled such that each covariate lies in [0, 1].
We introduce additional constraints to encode our dual objective in the optimal classification tree framework. We define the policy assignment probability
z it c t where c t is the policy assignment probability of leaf node t 2 ⌧ L , and z it describes whether or not instance i is assigned to leaf node t, enforced with the additional set of auxiliary big-M constraints for the product of a binary variable and continuous variable (for the case of two treatments).
The combined formulation for policy optimization with confounding-robust optimal trees is as follows:
Constraints (16d, 16e) set the policy assignment variable P i 2 [0, 1], which is the sum of products p i,t = z it c t over leaf nodes. Our objective is specified via the dual formulation, Figure 2 : Out of sample policy regret on simulated data in Sec. 7.1 and constraints (16b, 16c) encode the constraints from the dual of the inner maximization subproblem. Constraints (16f, 16g) enforce that if a node is in a leaf (as indicated by z it ), it satisfies the splits at ancestor nodes. Constraint (16h) enforces that each instance is in a leaf node, while constraint 16i enforces a size constraint on leaf membership. Constraints (16j, 16l, 16k) enforce consistency constraints between d, indicating whether a split occurs at leaf node t, and split variables a jt , b t . {D(t)} t2T B denotes the set of leaf nodes of smallest index which can be reached from splits at t, and similarly {U (t)} t2T B denotes the set of reachable leaf nodes of largest index. Constraints (16m, 16n, 16o) enforce that leaves are non-empty only if splits do occur in the relevant ancestor nodes. For the mixed-integer linear program, we provide a warm start for the optimization via a recursive partitioning-based approach which incrementally optimizes directly the robust risk, over iterative refinements of either the constant all-treat or all-control policy, described in Sec. B of the appendix.
Empirical Results
In this section we present empirical results on two experiments to investigate the benefit of confounding robustness. Our first experiment is a simple synthetic example that we use to illustrate the different methods in a controlled setting. Our second experiment investigates a large-scale clinical dataset on the treatment of acute ischaemic stroke. There, the harm done by unwarranted aggressive intervention by personalized policy learning led astray by confounding is serious, causing more deaths and other adverse effects than conservative standards of care. Our more careful approach to learning to personalized policies is able to avoid such harm but still offer sizable improvements over baseline by personalizing care.
Simulated data
We first consider a simple linear model specification demonstrating the possible effects of significant confounding on inverse-propensity weighted estimators. We generate our data as follows:
The constant treatment effect is 2.5 with the linear interaction treat = [ 1.5, 1, 1.5, 1, 0.5]. The covariate mean is µ x = [ 1, .5, 1, 0, 1] . The noise term ⇠ affects outcomes with coefficients ⌘ = 2, ! = 1, in addition to a uniform noise term ✏ ⇠ N (0, 1) . We let the nominal propensities be logistic in X,ê(X i ) = ( | x) with = [0, .75, .5, 0, 1, 0], and we generate T i according to the true propensities, which we set to
In particular, this makes e(X i , U i ) realize the upper bound in eq. (6) for = 1.5 when U i = 1 and the lower bound otherwise. We compare the policies learned by a variety of methods. We consider two commonplace standard methods that assume unconfoundedness: the logistic policy minimizing the IPW estimate with nominal propensities 4 and the direct comparison policy gotten by estimating CATE using causal forests and comparing it to zero (CF; Wager and Athey 2017b). We compare these to our methods with a never-treat baseline policy ⇡ 0 (x) = 0: our robust logistic policy using the unbudgeted uncertainty set, our robust logistic policy using the budgeted uncertainty set and multipliers ⇢ = 0.5, 0.3, 0.2, and optimal confounding-robust trees of depth 3. For each of these we vary the parameter in {0.3, 0.4, . . . , 1.6, 1.7, 2, 3, 4, 5}. For logistic policies, we run 15 random restarts of Alg. 1 with a step-schedule of  = 0.5 and return the one with the best robust objective value, unless the best robust objective value is positive, in which case we just return ⇡ 0 , which is feasible. We use Gurobi to solve the OCRT problem and set a time limit of 400 seconds for each solve.
For each of 50 replications, we generate an observational dataset of n = 200 according to the above model, run each of the above mentioned methods to learn a policy, and compute the true value of each learned policy (by using the known counterfactuals, which we generated). We report the value as the regret relative to the value of ⇡ 0 . We plot the results in Fig. 2 , showing the mean regret over replications along with the standard error (shaded regions).
Both the methods that assume unconfoundedness actually learn a policy that is worse than ⇡ 0 and that would introduce significant net harm if used in its place. By construction, for very small (left end of plot), our methods do not induce any robustness, assuming that true propensities are falsely similar to nominal, and the policy we learn matches the performance of the standard methods (IPW and CF) and similarly incurs some regret relative to control. When we add robustness, our policies achieve substantial improvements. As increases (middle of plot), the learned robust logistic policies are able to achieve negative regret, meaning we improve upon ⇡ 0 . As grows very large (right end of plot), we are very robust to any size of confounding and almost always default to ⇡ 0 as a policy that ensures never doing worse and our true regret converges to 0. Even in this extreme example of confounding where the true propensities achieve the odds-ratio bounds, the budgeted 
0.28 (0.03) 1.5 CRLogit. L1 0.5 0.38 (0.04) 1.5 CRLogit. L1 0.3 0.34 (0.04) 1.5 CRLogit. L1 0.2 0.43 (0.03) 1.5 version is able to attain similar improvements to the unbudgeted version for ⇢ = 0.3, 0.2, and uniformly better improvements for ⇢ = 0.5. These improvements are relatively insensitive to the exact value of ⇢ and the budgeted version is able to achieve improvement even when the budgeted uncertainty set is misspecified. In this example, OCRT suffers from the fact that the generation process we defined follows a linear non-axis-aligned structure, making it hard for a shallow tree to capture the effect heterogeneity. Specifically, the optimal policy in this setting is a linear policy which may be poorly approximated by an axis-aligned decision-tree policy. In real data, as in the example in the next section, trees usually fare better. In Table 1 , we summarize the results for the best parametric policies found in this case. The best improvements for the parametric policies are achieved at = 1.5, consistent with the model specification.
Assessment with Clinical Data: International Stroke Trial
We next build an evaluation framework for our methods from real-world clinical data, where the counterfactuals are not known, by using a large randomized clinical trial, creating a training set that is confounded by healthy user bias and evaluating on a test dataset using unbiased estimation based on known, constant treatment arm randomization probabilities. Specifically, we study data from the International Stroke Trial (IST), which assessed the clinical effectiveness of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke in a factorial experimental design. We focus on the aspirin and heparin (high dose) (T = 1) vs. only aspirin (T = 1) treatment arms from the original factorial design, numbering 7,233 cases with P (T = 1) = 1 /3 (International Stroke Trial Collaborative Group 1997). Findings from the study suggest a clear reduction in adverse events (recurrent stroke or death) from aspirin, whereas heparin efficacy is inconclusive since the small and non-significant benefit on rates of death at 6 months was offset by greater incidence of other adverse events such as hemorrhage or cranial bleeding.
The original trial measured a set of clinical outcomes including death, stroke recurrence, adverse effect, and recovery at various endpoints. We scalarize these clinical outcomes, penalizing adverse effects while recognizing the benefits of recovery, and summarize clinical outcomes in the following composite loss function: We construct an evaluation framework from the dataset by splitting off from the data a held-out test set and subsampling from the remaining patients in order to construct the confounded training data, which is then used to train personalized treatment assignment policies. To subsample the training data, we first choose each unit for inclusion with independent probability 0.6 + 0.3X age , where X age 2 [0, 1] is rescaled. Then, to introduce confounding that follows the healthy user bias pattern, among the selected treated patients we censor those with the worst 10% of outcomes and, similarly, we censor the 10% best patients in the control group. Such unobserved confounding generates a training dataset where heparin appears to lead to better outcomes. While the ATE estimate from the full data is ⌧ = 0.14 (significant), the difference in means between treated and control outcomes in the censored data is ⌧ = 0.29 (significant). Fitting an interacted linear model on the full-data suggests that treatment effects are heterogeneous with statistically significant interaction with such covariates as indicator of stroke subtype being "PACS," lack of brainstem/cerebellar signs, visible infarct on CT, and lack of face deficit, and symptoms noted on waking.
Given only the training data, we train treatment assignment policies that are personalized based on the recorded covariates available at the time of randomization. These covariates include age, indicators of conscious state, biological sex, blood pressure, and factors describing clinical assessments such as visible infarct on CT, arm/face deficit, leg/foot deficit, dysphasia, hemianopia, stroke subtype, visuospatial disorder, brainstem/cerebellar signs, and other deficit. We construct one-hot encodings of the categorical variables and train policies on 28 covariates after the dummy encoding. (Some covariates have categorical levels of "Yes," "No," or "Can't Assess".)
We again compare our approach to two standard methods that assume unconfoundedness: IPW and CF. We compare these to our confounding-robust approaches with logistic assignment policies using unbudgeted uncertainty (CRLogit) and budgeted uncertainty with parameter ⇢ = 0.5 (CRLogit.L1) and with the optimal confounding-robust tree-based policy (OCRT). We let nominal propensities be given byê(X i ) = 0.2 + 0.1X i,age . We use the same algorithm parameters as in the last section.
Without access to the true counterfactual outcomes for patients, we evaluate the performance of policies out of sample by using an unnormalized Horvitz-Thompson estimator on the held-out truly-randomized data from the clinical trial. For the out-of-sample evaluation we use Horvitz-Thompson rather than Hájek because it is unbiased and therefore allows for a fair comparison of different methods. In the RCT, the probabilities of completely randomized treatment assignment, as reported above, are p 1 = . Correspondingly, our out-of-sample estimate of policy regret relative to ⇡ 0 (x) = 0 based on the held-out dataset S test is given byR
We run 10 replications, in each of which we construct a random train-test split, subsample the training data as described above, train the various personalized policies, and evaluate them out of sample on the test data. We plot resulting mean regret over replications (along with standard error) in Fig. 3 . We see first of all that the standard approaches to policy learning introduce significant harm relative to the aspirin-only baseline. In this example, the harm is real, corresponding to deaths and adverse health effects and highlighting the dangers of unchecked policy learning and the impediments to the implementation of standard methods. As before, by construction, for very small (left end of plot) our policies perform similarly to methods that assume unconfoundedness. As increases, our methods achieve significant policy improvement. The logistic unbudgeted policy (CRLogit) achieves the best average test performance of 0.14 at = 0.4. For 0.9, the robust optimization objective is not able to find a policy that so-uniformly improves upon control and returns ⇡ 0 , which of course induces no harm. The logistic budgeted policy (CRLogit.L1) achieves the best estimated improvement of 0.22 at = 0.5. As increases, the budgeted policy finds a policy estimated to do well, although it treats very few people, as we discuss in the next comparisons. The optimal confounding-robust trees (OCRT), in optimizing over the space of constant-probability trees of maximum depth 3, achieve the best performance of around 0.12 at = 0.5. Although OCRT does not do better than the logistic policies, it offers similar performance with an exceedingly simple and highly interpretable policy, which is an important feature in clinical decision making.
In Figs. 4a and 4b, we further study the behavior of the different policies to understand these differences in performance. The former shows how many patients are targeted for treatment and the latter shows the prognosis score among those targeted for treatments. The IST trial recorded a prognosis score of predicted probability of death at 6 months using an externally validated model. Because this model uses the same covariates as the ones observed and used to derive the personalization, we do not include the score as an independent covariate for policy learning, but now consider this score to assess the validity of our robust policy as an externally validated indicator of patient severity. Fig. 4a shows that the standard methodologies over-intervene with aggressive heparin treatment, which explains their bad performance in practice. Our robust policies carefully target whom to treat, or, for very large , treat no one. Fig. 4b helps us understand who are the patients that our policies picked out for more aggressive treatment. We see that our policies target patients with overall larger-than-average prognosis score, indicating that our policies are learning and treating on appropriate indicators of severity from the available covariates. Note that the standard errors in Fig. 4b get larger for larger because fewer are treated. (And, for sufficiently large , CRLogit treats no one so its curve ends.) Though the robust budgeted policy (CRLogit.L1) obtains a very slightly negative objective value for > 0.9, we see that the resulting treatment policy treats very few and only the most severe patients. Our learned policies suggest that improvements from heparin may be seen in the highest-risk patients, consistent with the findings of Berge and Sandercock (2002) . After a systematic review comparing anticoagulants such as heparin against aspirin, Berge and Sandercock (2002) conclude from a study of trials including IST that heparin provides little therapeutic benefit, with the caveat that the trial evidence base is lacking for the highest-risk patients where heparin may be of benefit. Thus, our robust method appropriately treats those, and only those, who stand to benefit from the more aggressive treatment regime.
In Table. 2 we decompose the policy regret by subgroup, showing the average withinsubgroup regret as well as the percentage that the group comprises of the population. We compare IPW and CF with the best policies found by our methods. This allows us to see which groups each policy may be helping and which it may be hurting. (Note that some percentages do not add up as there may be a third category such as "Can't Assess.") We find that the improvement from our treatment policies is generally achieved uniformly for all subgroups, except for the subgroup of "Stroke Type: Other," which is rare with only 22 individuals of that subtype in the whole dataset. Thus, although the guarantee only ensures a net improvement, we find that almost every subgroup benefits from our precise-yet-safe targeting. Both IPW and CF learn the treat-all policy, which induces harm for almost all subgroups.
Conclusion
In this paper, we addressed the problem of learning personalized intervention policies from observational data with unobserved confounding. Standard methods can be corrupted by this confounding and lead to harm compared to current standards of care, a concern of utmost importance in sensitive applications such as medicine, public policy, and civics. We therefore develop a framework for confounding-robust policy improvement, which optimizes personalization policies in view of possible unobserved confounding in observational data, allowing for more reliable and credible policy evaluation and learning. Our approach optimizes the minimax regret achieved by a candidate personalized decision policy against a baseline policy. We generalize the class of IPW-based estimators and construct uncertainty sets centered at the nominal IPW weights that can be calibrated by approaches for sensitivity analysis in causal inference. A future line of investigation is a confounding-robust variant based on the doubly robust estimator of policy value.
We prove a strong statistical guarantee that, if the uncertainty set is well-specified, our approach is guaranteed to do no worse than the standard of care so that it can be safely implemented, and possibly offer improvement if the data can support it. Specifically, the result proved a finite-sample guarantee that can be checked. We leverage the optimization structure of weight-normalized estimators of the policy value to perform policy optimization efficiently by subgradient descent on the robust risk, or optimizing over the space of decision trees. Assessments on synthetic and clinical data demonstrate the benefits of confounding-robust policy improvement, which can recommend personalized treatment while maintaining strong guarantees on performance relative to baseline preferences. These tools allow an analyst to find reliable and personalized policies that can safely offer improvements even if there is unobserved confounding and to assess the implications of different plausible levels of confounding on the performance of a robust personalized decision policies. We believe this development is absolutely crucial for the practical adoption of algorithms for personalization that work on the ever growing repositories of observational data, which are the future of algorithmic decision making due to their size and richness.
Appendix

A Proofs
Proof. Proof of Lemma 1. Notice that:
Consequently, for t sign(x) = 1, the joint distribution of Y, T, X follows the factorization
which as shown above is independent of ✓. Whenever t sign(x) = 1, we have Y = T X + 3.6✏. Consequently, for t sign(x) = 1,the joint distribution of Y, T, X follows the factorization
It follows that the distribution of the observed data Y, T, X, is as follows:
t sign(x) = 1, y = 0 0 otherwise which is independent of ✓.
Note that if |z 2|  ✏  1 then |z 2| /z  |z 2|  ✏. Therefore, by eq. (17) as well as 2 Z  2. Let ⇡ CR (x) = 1/2 be the complete randomization policy so that
Note that
Moreover, note that for any ⇡,
Next, note that by assumption (W ⇤ 1 /t, . . . , W ⇤ n /t) 2 U for some t > 0. Therefore,
which completes the proof.
Proof. Proof of the equivalence of programs (12) and (13). We can easily verify that a feasible solution for one problem is feasible for the other: for a feasible solution W to (FP), we can generate a feasible solution to (LP) as w i =
with the same objective value. In the other direction, we can generate a feasible solution to (13) from a feasible fractional program (12) solution W, t if we take w i = w i t. This solution has the same objective value since P i w i = 1. Proof. Proof of Thm. 2. We analyze the program using complementary slackness, which will yield an algorithm for finding a solution that generalizes that of Aronow and Lee (2012) .
At optimality only one of the weight bound constraints, for nontrivial bounds a , b , w i  b i or a i  w i will be tight. For the nonbinding primal constraints, by complementary slackness the corresponding dual variable u i for constraint a i  w i or v i for w i  b i will be 0. Thus, a total of n + 1 constraints are tight in the dual (since t > 0 and the constraint is not binding), including the constraint P i b i v i + a i u i 0. So the optimal solution to the dual will satisfy: min s.t. r i + u i v i , 8i 2 1, . . . , n X i b i v i + a i u i = 0
Note that u i > 0 if Y i < and v i > 0 if Y i > . Then at optimality, there exists some index (k) (where (k) refers to the kth index of the increasing order statistics, an ordering where r (1)  r (2 )  · · ·  r (n) .
We can subsitute in the solution from the binding constraints = r i + u i v i and obtain the following equality which holds at optimality: X i:(i)<(k) b (i) . Thus by complementary slackness, is the optimal value with the corresponding optimal solution exhibited above. Therefore, we need only check the possible objective value (k) for k = 1, . . . , n.
The optimal such occurs with the order statistic threshold at (k) for k ⇤ = inf{k = 1, . . . , n + 1 : (k + 1) < (k)}. Consider the parametric restriction of the primal program, parametrized by the sum of weights t; the value function is concave in t and furthermore concave in the discrete restriction of t to the values it takes at the vertex solutions.
B Recursive Partitioning: MIP Warm Start
We provide a heuristic recursive-partitioning based scheme for optimizing policy risk over the space of limited-depth decision trees recursively, analogous to CART's recursive partitioning approach (Breiman et al. 1984) . Such an approach is used to obtain a warm start for the MIaP of the optimal confounding-robust tree. The algorithm initializes by assigning the same treatment ⌧ 0 to all, and iteratively refines the treatment assignment by recursive partitioning, seeking univariate splits which minimize the minimax risk. The candidate split threshold for each covariate is determined by iteratively re-evaluating the minimax risk for incremental changes to the policy, maintaining the invariant that the base policy is set by the leaves above a node in the tree. Using specialized data structures such as B-trees allows for O(log(N )) efficient updates for maintaining and updating the sorted list of multipliers Y i T i (⇡ i ⇡ 0 ), and manipulating pre-computed cumulative sums of the initial sorted order allows for efficient re-computation of the optimization solution. We note that such an approach is possible only for the unbudgeted uncertainty set U n , since incorporating the uncertainty budget would couple the risk across tree levels.
In comparison to other approaches using tree-based approaches for estimating causal effects (Wager and Athey 2017b) or for personalization (Kallus 2017a) , which consider splits based on impurities related to the expected mean squared error of causal effects on a separate sample of data from that used to estimate the causal effects within leaves, or determine the optimal treatment, our recursive partitioning heuristic simultaneously determines the partition and the policy treatment assignment within the partition. In making greedy splits, changes in the objective function are assessed as a result of changing the policy assignment within S L,l , and the optimal split location and sense (I[a | X < b] or I[a | X > b]) are determined by changes in the policy assignment within S L,l . However, in general, the optimal such policy assignment, determined incrementally from the assignments {S L 1,l } l2T L , depends additionally on the assigned policy for other nodes at the same level as well.
C Additional Experimental Details
In the simulated example in Sec. 7.1 and the example on IST data in Sec. 7.2, we additionally assess the performance of a self-normalized counterfactual policy maximizer, SNPOEM (Swaminathan and Joachims 2015a) . This approach adds both a variance regularization and a self-normalization, both of which strongly bias the learned policy toward the logging policy. While this has merit, it results in spuriously inconsistent results across the problems we consider, where in one it has reasonable results and in another much worse results than any other standard method. Specifically, SNPOEM achieves a mean policy value of 0.82 (SD 0.04) in the simulated example and 0.04 (SD 0.029) in the IST example. Because this additional layer of complexity only confuses the comparisons and the main focus on the contrast between ignoring and accounting for unconfoundedness, we omit these results from the main text.
